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Abstract
Background: Accurate estimates of incidence and prevalence of the disease is a vital step toward
appropriate interventions for chronic disease like diabetes. A growing body of scientific literature
is now available on producing accurate information from administrative data. Advantages of use of
administrative data to determine disease incidence include feasibility, accessibility and low cost, but
straightforward use of administrative data can produce biased information on incident cases of
chronic disease like diabetes. The present study aimed to compare criteria for the selection of
diabetes incident cases in a medical administrative database.
Background
Diabetes is one of the most costly and burdensome
chronic diseases of our millennium [1]. According to the
latest World Health Organization report, more than 180
million people worldwide suffer from diabetes. This
number will very likely double by 2030[2]. Therefore,
public health prevention and intervention are urgently
needed.
Planning, implementing and monitoring of appropriate
intervention for this disease requires accurate estimates of
incidence and prevalence of the disease. Although surveys
are used for precise estimation of prevalence and inci-
dence, they are very expensive and time consuming. Alter-
native methods include secondary analysis of existing
data and use of administrative data [3,4]. Advantages of
use of administrative data to estimate disease incidence
include easy access, low cost, and availability of data over
long and continuous periods. Research by Blanchard and
colleagues in Manitoba and Hebert et al. in the United
States showed that health care administrative data can be
used to identify individuals diagnosed with diabetes mel-
litus and estimate rates over time[1,5,6]. Occurrence of
diabetes was defined as two physician claims with a diag-
nosis of diabetes (ICD-9 code 250) on 2 different days
within 2 years or one hospital discharge with a diabetes
diagnostic code in any of the 16 diagnosis fields. They
found an approximately 95% sensitivity of their diabetes
case definition from administrative data compared to a
diabetes education registry [1,6]. As a result, this diabetes
case definition algorithm has been adopted by the Cana-
dian National Diabetes Surveillance System (NDSS) [7].
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However, there are several potential pitfalls of administra-
tive data to estimate disease incidence [8]. One general
problem is representativeness of administrative data. In
Canada with universal health insurance coverage, the
health services are provided to all residents; therefore,
almost all Canadians are represented by these datasets
(details available from the Canada Health Care System
website) [9]. The other challenge in this respect is related
to multiple utilizations of health services by a single
patient. In principle, record linkage allows detection of
multiple records of the same patient [8,10], but it is diffi-
cult to define which records should be considered to be
the starting point of the care episode. In this paper, we
compare different methods to identify incident cases of
diabetes using Quebec health service data.
Methods
Study Database
A retrospective population-based cohort was constructed
using data from the Régie de l'Assurance Maladie du Québec
(RAMQ) and the registry Maintenance et exploitation des
données pour l'étude de la clientèle hospitalière (Med-Echo).
The RAMQ provides universal health insurance for Que-
bec inhabitants, which includes coverage for physician
and hospital services, as in other Canadian provinces. For
each physician service, the patient's identification, date of
service, diagnosis (a four digit ICD-9 code), and service
code are entered into a "physician claims" database. Sim-
ilarly, after each hospital discharge, Quebec hospitals sub-
mit a discharge summary that includes the patient's
identification, dates of admission and discharge, attend-
ing physicians, main reason for admission and up to 16
ICD-9 diagnoses. These hospital discharge records consti-
tute the Med-Echo registry. The accuracy of this adminis-
trative health data has been demonstrated for a number of
medical conditions [11,12]. All databases were also linked
using a unique encrypted number that preserved the exact
identification of individuals but allowed for the examina-
tion of individuals across the administrative databases.
Study Population
The study population includes all individuals 20 years old
or older living in the province of Quebec in 2002. The
date of the first claim for diabetes or hospitalization in the
year 2002 was defined as the index date. We excluded
women with gestational diabetes mellitus. To eliminate
gestational diabetes any record with an obstetrics event
within 5 months of the index date was excluded.
Methodology
A single cohort was selected to determine incident cases of
diabetes. The 2002 cohort was selected as an example of
application. This cohort provided 10 years of retrospective
observation to exclude previous cases. A diabetes case was
defined according to the Canadian National Diabetes Sur-
veillance System (NDSS) case definition: two physician
claims with a diagnosis of diabetes (ICD-9 Code 250) on
2 different days within 2 years or one hospital discharge
with a diabetes diagnosis code in any field among 16 diag-
nosis codes. To find the cases we started from the date of
the first claim for diabetes or hospitalization in the year
2002, whichever came first. To apply the definition, the
databases were observed for the 720 days before the index
date. To differentiate between prevalent cases and inci-
dent cases, a minimum diabetes-free retrospective obser-
vation period (clearance period) and a definition for
repeated cases were needed. Our options for identifying
repeated cases were using NDSS case definition (one hos-
pitalization record or two physician claims during 2 years)
or using a single record of ICD-9 code 250 (in hospital
database or medical service database) during the retro-
spective observation period. In this study NDSS case defi-
nition criteria is called "NDSS method" and a single
record of ICD-9 code 250 is called "one hit method ". To
define the cut-off point for a clearance period for each
index case in 2002, the backward time to the previous
event was separately calculated using NDSS method and
using the one hit method. Time was measured in days
from the index point. The maximum (backward) observa-
tion period was 3650 days.
The Population at risk of diabetes at the beginning of the
year 2002 includes people not diagnosed with diabetes
and new cases of diabetes. As it was shown in figure 1, the
population not diagnosed with diabetes before 2002 was
determined (population at risk at the end of the year
2002). Then the population with a diagnosis of diabetes
before 2002 (prevalent cases) was also determined. The
newly diagnosed cases in the year 2002 were identified
representing incident cases of diabetes during 2002.
Statistical Analysis
Descriptive statistics and McNemar matched pair chi-
square test are used to compare the NDSS method and the
one hit method to exclude prevalent cases.
Kappa statistics is used to show the level of agreement
between different lengths of observation periods and ten
years as the maximum observation period. Kappa values
are categorized as follows by Byrt[13,14] values between -
1 and 0 indicate "no agreement"; between 0 and 0.20
indicate "poor agreement"; between 0.21 and 0.40 indi-
cates "slight agreement"; between 0.41 and 0.60 indicates
"fair agreement"; between 0.61 and 0.80 indicates "good
agreement"; between 0.81 and 0.90 indicates "very good
agreement"; and between 0.91 and 1.0 indicates "excel-
lent agreement".
Next, The probability of being an incident case (being free
of retrospective event) at different times (cut-points) isBMC Medical Research Methodology 2009, 9:62 http://www.biomedcentral.com/1471-2288/9/62
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Selection criteria to identify incident cases of diabetes in the Quebec health service database Figure 1
Selection criteria to identify incident cases of diabetes in the Quebec health service database. *NDSS: National 
Diabetes Surveillance System case definition in Canada
Diabetes cases in 2002 
using NDDS* case definition  
n=265, 050 
Diabetes cases 
(NDDS case definition) 
n=263, 213 
Exclusion criteria: 
Gestational diabetes 
n=1873
Exclusion criteria for prevalent case 
One hit method  NDSS method 
Incident cases 
n=37, 473 
Incident cases 
n=41, 261 
Incident cases 
n=33, 498 
Incident cases 
n=38, 342 
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calculated by retrograde survival function. By this
method, survival (being an incident case) at a given time
is the conditional probability of surviving (not having a
preceding record) to a specific time given that the individ-
ual is at risk for the event (having a preceding record) at
that time. To find the cut-off point, we assumed that there
is a time when all previous cases have been accounted and
the patient is no longer at risk of a previous event. The cut-
off point of the clearance period will be considered the
point that the probability for being at risk of a previous
event begins to remain constant. Statistical analyses were
performed using SAS 9.1[15].
Ethical considerations
This project was approved by the Ethics Review Board of
the Faculté de médecine of the Université de Sherbrooke and
the Commission d'accès à l'information du Québec.
Results
There were 5,686255 adults, 20 years old or older for the
year 2002. A total of 263,213 patients met the NDSS case
definition for being a diabetes case (figure 1). Using the
one hit method provided 33,498 incident cases (inci-
dence proportion 1.08) over a clearance period of ten
years. Applying the NDSS method and a ten-year clear-
ance period, 38,342 incident cases of diabetes (incidence
proportion 1.24) were found. There was a significant dif-
ference between the two case definition criteria using the
McNemar matched pair chi-square test (P < 0.0001).
Cross-tabulations of incident cases and duration of the
clearance period shows that diabetes incident cases
decrease when the clearance period increases (Table 1).
Using the one hit method, the agreement between a ten-
year and a nine-year clearance period is excellent (kappa >
0.99). The agreement is also excellent between a ten-year
clearance period and clearance periods of four years or
more (kappa > 0.90). The agreement changed to very
good (kappa > 0.85), good (kappa > 0.74), and fair
(kappa > 0.43) when a three, two and one-year clearance
period was used, respectively. Results using the NDSS
method were similar and showed that agreements
between a ten-year clearance period and clearance periods
of four years and more were excellent (Table 1).
The estimation using survival function by one hit method
for eliminating prevalent cases at one year (365 days) was
(0.35, SE = 0.0009) (Figure 2). There was a reduced and
non-constant risk for a preceding record of diabetes occur-
ring at 1600 days (0.15, SE = 0.0006) before the index
point in 2002 and the observed risk remained constant
1900 days prior to the index point (0.14, SE = 0.0006). We
observed a similar pattern using the NDSS method, i.e.
the observed risk remained constant 1900 days prior to
the index point (0.15, SE = 0.0006).
Discussion
Previous studies on diabetes incidence for Canadian
adults from administrative data relied on the NDSS
(National Diabetes Surveillance System) case definition
and employed a free observation period to remove the
prevalent pool effect [1,6]. In our study, the retrograde
survival function showed that a five-year clearance period
is a reliable clearance period to distinguish new cases in a
prevalent pool. Even if the kappa agreement is excellent
after four years we did proceed with retrograde survival
function to take into account the high prevalence of
patients with diabetes in the database.
Diabetes is an insidious disease which may go undiag-
nosed for many years. In this retrograde method, we
started with the diabetes cases who already met the criteria
of NDSS in the year 2002. Canadian studies show the
NDSS case definition has a sensitivity above 86%; specifi-
city around 97%; and positive predictive values of 80%
[1,6]. We aimed to eliminate prevalent cases from inci-
dent cases identified by the NDSS case definition so that
high sensitivity and less selection bias were of main inter-
est. According to our study, there was a significant differ-
ence between the NDSS method and the one hit method
(P < 0.0001) to identify diabetes incident cases. The differ-
ence is 1.4% (3788) for a 5-year clearance period using
one hit method and 1.8% (4844) for a 10-year clearance
period for the NDSS method. This finding confirms those
of previous studies [6]. As reported by Wilson, the use of
more than one ICD-9 code 250 to find diabetes cases in
an administrative database for a three- year period results
in significant loss of sensitivity, and specificity of a single
ICD-9 code 250 is nearly the same as the use of two ICD-
9 codes 250 [16]. On the other hand this result could be
interpreted within the context of the study's design. A
large administrative dataset, provides sufficient sample
size to observe relations, and the more restricted defini-
tion for NDSS method (i.e. Two physician visits or one
hospitalization within two years) than the one hit method
thus for choosing between two methods, considering
both work similarly, an easier method which is slightly
more sensitive is superior to a more difficult method
which is somewhat less sensitive.
In practice, it is usual to exclude patients who received the
same diagnosis several years before the beginning of the
study period [6,1,17]. Previous studies used different cut-
off points for clearance periods based on the length of reg-
istration years in the databanks [6,1,17]. In our study, we
used the kappa agreement method [13] and retrograde
survival function to validate the optimal clearance periodBMC Medical Research Methodology 2009, 9:62 http://www.biomedcentral.com/1471-2288/9/62
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for determination of diabetes incidence from administra-
tive data.
We found excellent agreement (kappa > 0.90) between a
10-year clearance period and a clearance period of 4 years
or more. However such a high agreement (kappa > 0.90)
may be related to the high prevalence of cases in our data-
base [13]. For this reason, we continued our analysis by
retrograde survival function. This method showed that
five years is an appropriate duration for a clearance period
and the observed risk of being a repeated case remained
constant thereafter.
The accuracy of our incidence estimation may also be
affected by validity of diagnosis codes recorded in admin-
istrative databases and time. Canadian studies on admin-
istrative data showed that there is a good agreement
between recorded cases in administrative databases and
self-reported disease [11,18]. To evaluate the effect of the
cohort of index time (2002 in our study) on the chance of
being a preceding case, we evaluated reproducibility of a
10-year vs. 5-year clearance period for different index
years including 1999, 2000. We found kappa > 0.90 in all
cases (data not shown).
We also evaluated the consistency of a five-year clearance
period when different selection criteria were used. Kappa
were > 0.90 between a clearance period of 10 years vs. a
clearance period of 4 years or more whether one hit
method or NDSS method were used.
Table 1: New cases of diabetes and kappa agreement by clearance period and exclusion criteria
Exclusion criteria for prevalent case
One hit method NDSS* method
Clearance 
period (years)
Number of new 
cases
Incidence 
proportion**
Kappa 
agreement***
Number of new 
cases
Incidence 
proportion**
Kappa 
agreement***
1 91872 2.9% 0.427
(0.420-0.432)†,§
91872 2.9% 0.482
(0.479-0.485)†,§
2 52508 1.7% 0.739
(0.731-0.742)†,§
52508 1.7% 0.810
(0.801-0.822)†,§
3 43473 1.4% 0.849
(0.845-0.851)†,§
45525 1.5% 0.898
(0.896-0.900)†,§
4 39595 1.33% 0.900
(0.900-0905)†,§
42791 1.4% 0.936
(0.933-0.937)†,§
5 37473 1.23% 0.935
(0.933-0.937)†,§
41261 1.3% 0.957
(0.956-0.958)†,§
6 36111 1.16% 0.957
(0.955-0.958)†,§
40218 1.29% 0.971
(0.970-0.973)†,§
7 35094 1.14% 0.973
(0.972-0.974)†,§
39475 1.28% 0.982
(0.981-0.983)†,§
8 34400 1.11% 0.985
(0.983-0.986)†,§
38975 1.26% 0.990
(0.989-0.991)†,§
9 33932 1.09% 0.993
(0.992-0.994)†,§
38627 1.25% 0.996
(0.995-0.996)†,§
10 33498 1.08% 100 38342 1.24% 100
*: National Diabetes Surveillance System case definition in Canada.
**: Incidence proportion = (Number of incident cases of diabetes for the year 2002/population at risk of diabetes for the year 2002)*100; number 
of diabetes cases for the year 2002 using NDSS case definition criteria is 263,213; population of 20 years old or older for the year 2002 is 5,686,255;
***: Agreement between 10 years (expected) and observed clearance period according to the clearance period and exclusion criteria for prevalent 
case;
†: 95%Confidence interval;
§: P < 0.0001, Chi-square test statistic for homogeneity.BMC Medical Research Methodology 2009, 9:62 http://www.biomedcentral.com/1471-2288/9/62
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Our study has some limitations. We used medico-admin-
istrative data to find the incident cases. This may underes-
timate the real incidence because most people with
diabetes remain asymptomatic for years after onset of the
disease and because only patients who received health
care services are entered in these databases [19,20]. In
Canada with universal insurance coverage, every encoun-
ter with the health system is recorded in medico-adminis-
trative registries. To ensure patients encountered the
health services during the clearance period (of any diag-
nosis) we examined the 37473 incident cases of diabetes
for records related to other services and only 1301 (3.5%)
had no record related to another kind of service. There are
three possible conditions that could result in non-detec-
tion of potential cases of diabetes during the study period:
1-People who did not need the services; 2-diabetic
patients who used services for other reasons; 3-sick people
who left the country.
One study in Manitoba showed the probability of 0.96 for
diabetic patients to have a subsequent medical contact for
the diabetes within two years [1]. A validation study using
patient records and administrative data in Ontario
showed sensitivity for diabetes was 90 and 86%; for the 1-
and 2-claim algorithms, specificity was 92 and 97%,
respectively, and positive predictive values were 61 and
80%, negative predictive values were 99 and 98%, respec-
tively [6]. On the basis of Canadian census data on out-of-
country and out-of-province migrations, we estimated
that fewer than 5% of these patients would have migrated
in or out of Quebec during the study period (details avail-
able from Statistics Canada). Therefore the missed data
was unlikely to substantially affect the reported results.
In our database, it was not possible to differentiate
between diabetes type 1 and type 2.
The results may not be representative for the younger pop-
ulations with diabetes because patterns and temporal evo-
lution of disease is different between diabetes type 1 and
type 2 and incidence of the former is higher in young pop-
ulations. Furthermore, we did not assess clearance periods
of more than ten years. However the results of our retro-
grade survival function analyses showed stabilization of
risk of being a previous case after a clearance period of 5
or more years.
Conclusion
Use of recorded administrative data to estimate incidence
of diabetes using either the Canadian National Diabetes
Surveillance System definition or one ICD-9 code 250
produces biased estimates in part because of inclusion of
prevalent cases as incident cases. A clearance period of 5
years or more is sufficient to improve performance of this
convenient, accessible and inexpensive method to esti-
mate incidence of diabetes.
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